1. Home
  2. PCRX

PCRX

Pacira BioSciences Inc.

Logo Pacira BioSciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Founded: 2006 Country:
United States
United States
Employees: N/A City: TAMPA
Market Cap: 1.2B IPO Year: 2011
Target Price: $49.50 AVG Volume (30 days): 497.3K
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.89 EPS Growth: 161.76
52 Week Low/High: $25.93 - $48.60 Next Earning Date: 05-01-2024
Revenue: $674,978,000 Revenue Growth: 1.22%
Revenue Growth (this year): 4.62% Revenue Growth (next year): 9.87%

Share on Social Networks:

Stock Insider Trading Activity of Pacira BioSciences Inc. (PCRX)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
PACE GARY W PCRX Director Mar 6 '24 Sell $29.67 1,066 $31,628.22 140,384 SEC Form 4
PACE GARY W PCRX Director Mar 6 '24 Sell $30.81 28,257 $870,598.17 112,127 SEC Form 4
PACE GARY W PCRX Director Mar 6 '24 Sell $30.60 90,000 $2,754,000.00 22,127 SEC Form 4